Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value.
K Sekiya, … , J M Polak, S R Bloom
K Sekiya, … , J M Polak, S R Bloom
Published June 1, 1989
Citation Information: J Clin Invest. 1989;83(6):1834-1842. https://doi.org/10.1172/JCI114089.
View: Text | PDF
Research Article

Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value.

  • Text
  • PDF
Abstract

GAWK (chromogranin-B 420-493) is a 74 amino acid peptide recently isolated from human pituitaries. Using two different antibodies (directed against GAWK [1-17] and [20-38] fragments) GAWK-LI was measured in tumors from 194 patients and in the plasma of 434 patients by RIA. The highest tissue concentrations of GAWK-LI were found in pheochromocytoma (GAWK [1-17]-LI, 18,173 +/- 3,915; GAWK [20-38]-LI, 17,852 +/- 2,763 [mean +/- SEM] pmol/g wet wt tissue; n = 9), which were at least ten times higher than any other tumors producing GAWK-LI. High concentrations of GAWK-LI were also found in other types of endocrine tumors including carcinoid, medullary carcinoma of thyroid, pancreatic, and ACTH-producing lung tumors. On the other hand, low concentrations of GAWK-LI were found in nonendocrine tumors. Plasma concentrations of GAWK-LI were found to be elevated in patients with endocrine tumor, but more so in those with pancreatic tumors than with pheochromocytomas. Plasma concentrations returned to normal after successful tumor removal. Chromatographic profiles of GAWK-LI in extracts of pheochromocytomas and normal adrenals showed high molecular weight peaks that were absent in the extracts of other endocrine tumors and normal pancreas, suggesting differential tissue-specific processing. Thus GAWK-LI is produced by a variety of endocrine tumors and may serve as a plasma tumor marker, especially in patients with pancreatic endocrine tumors.

Authors

K Sekiya, M A Ghatei, M J Salahuddin, A E Bishop, Q A Hamid, H Ibayashi, J M Polak, S R Bloom

×

Total citations by year

Year: 2024 2018 2015 2014 2013 2011 2010 2009 2008 2007 2006 2005 2003 1998 1995 1993 1992 1991 1990 1960 Total
Citations: 1 1 1 1 3 1 2 1 1 1 1 1 1 2 1 1 5 1 1 1 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
Поиск новых иммуногистохимических и циркулирующих маркеров инсулиномы
Юкина МЮ, Трошина ЕА, Урусова ЛС, Нуралиева НФ, Никанкина ЛВ, Иоутси ВА, Реброва ОЮ, Мокрышева НГ
Problems of Endocrinology 2024
Role of biomarker tests for diagnosis of neuroendocrine tumours
J Hofland, WT Zandee, WW de Herder
Nature Reviews Endocrinology 2018
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours
PJ Monaghan, A Lamarca, JW Valle, RA Hubner, W Mansoor, PJ Trainer, D Darby
Clinical Endocrinology 2015
Characterization and Plasma Measurement of the WE-14 Peptide in Patients with Pheochromocytoma
J Guillemot, M Guérin, E Thouënnon, M Montéro-Hadjadje, J Leprince, H Lefebvre, M Klein, M Muresan, Y Anouar, L Yon, S Gasman
PloS one 2014
Mass spectrometry identification of granins and other proteins secreted by neuroblastoma cells
W Rozek, M Kwasnik, J Debski, JF Zmudzinski
Tumor Biology 2013
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study
R Dobson, MI Burgess, M Banks, DM Pritchard, J Vora, JW Valle, C Wong, C Chadwick, K George, B Keevil, J Adaway, JE Ardill, A Anthoney, U Hofmann, GJ Poston, DJ Cuthbertson, P Holvoet
PloS one 2013
The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia
Bech, NM Martin, R Ramachandran,
Annals of Clinical Biochemistry 2013
The Pituitary
X Bertagna, L Guignat, MC Raux-Demay, B Guilhaume, F Girard
The Pituitary 2011
Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma
M Guérin, J Guillemot, E Thouënnon, A Pierre, FZ El-Yamani, M Montero-Hadjadje, C Dubessy, R Magoul, I Lihrmann, Y Anouar, L Yon
Regulatory Peptides 2010
Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors
JM Conlon
Regulatory Peptides 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy
P Bech, V Winstanley, KG Murphy, AH Sam, K Meeran, MA Ghatei, SR Bloom
The Journal of clinical endocrinology and metabolism 2008
Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis
N Mattsson, U Rüetschi, VN Podust, M Stridsberg, S Li, O Andersen, S Haghighi, K Blennow, H Zetterberg
Journal of Neurochemistry 2007
Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma
J Guillemot, Y Anouar, M Montero-Hadjadje, E Grouzmann, L Grumolato, J Roshmaninho-Salgado, V Turquier, C Duparc, H Lefebvre, PF Plouin, M Klein, M Muresan, BK Chow, H Vaudry, L Yon
International Journal of Cancer 2006
Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances
RR Warner
Gastroenterology 2005
The Chromogranin–Secretogranin Family
L Taupenot, KL Harper, DT O'Connor
New England Journal of Medicine 2003
Chromogranin A: its clinical value as marker of neuroendocrine tumours
Nobels, Kwekkeboom, Bouillon, Lamberts
European Journal of Clinical Investigation 1998
Argyrophilia and chromogranin A and B immunostaining in patients with sporadic medullary thyroid carcinoma. a critical appraisal of their prognostic utility
L Scopsi, G Sampietro, P Boracchi, P Collini
The Journal of Pathology 1998
Identification of a new chromogranin B fragment (314–365) in endocrine tumors
MC Woussen-Colle, P Gourlet, A Vandermeers, MC Vandermeers-Piret, J D'Haens, B Velkeniers, P Robberechi
Peptides 1995
Posttranslational processing of proenkephalins and chromogranins/secretogranins
L Dillen, B Miserez, M Claeys, D Aunis, WD Potter
Neurochemistry International 1993
Differential regulation of chromogranin B/secretogranin I and secretogranin II by forskolin in PC12 cells
ME Thompson, WE Zimmer, LB Wear, LA MacMillan, WJ Thompson, WB Huttner, H Hidaka, JG Scammell
Molecular Brain Research 1992
The chromogranins A and B: The first 25 years and future perspectives
H Winkler, R Fischer-Colbrie
Neuroscience 1992
Production of chromogranin A and B derived peptides in human small cell lung carcinoma cell lines
H Iguchi, S Bannai, N Takanashi, Y Tsukada
European Journal of Cancer 1992
Pulmonary Endocrine Pathology
JR Gosney
Pulmonary Endocrine Pathology 1992
Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung
M Tötsch, LC Müller, A Hittmair, D Öfner, AR Gibbs, KW Schmid
Human Pathology 1992
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study
KW Schmid, A Hittmair, D Ladurner, P Sandbichler, R Gasser, M Tötsch
Virchows Archiv A Pathological Anatomy and Histopathology 1991
Gut endocrine and neural peptides
AE Bishop, JM Polak
Endocrine Pathology 1990
Cushing's disease
EJ Carry, I Walzer
The American Journal of Surgery 1960

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts